Top Story

Salpingectomy may reduce risk for ovarian cancer

February 27, 2015

Surgical removal of the fallopian tubes may help reduce a woman’s risk for ovarian cancer even if her ovaries are left intact, according to study results.

The findings support prior research that suggests a considerable proportion of ovarian cancers begin in the fallopian tubes or uterus, potentially contributing to late-stage diagnoses and poor outcomes.

Richard T. Penson, MD In the Journals

Bevacizumab does not hinder quality of life for women with advanced cervical cancer

February 25, 2015
The addition of bevacizumab to treatment regimens for patients with advanced cervical cancer improved survival without sacrificing quality of life, according to…
Jason D. Wright, MD In the Journals

Cancer prevalence low in women who undergo myomectomy with electric power morcellation

February 20, 2015
The prevalence of cancer and precancer abnormalities in the uterus was low among women who underwent myomectomy with electric power morcellation, according to…
In the Journals

9-valent HPV vaccine noninferior to quadrivalent HPV vaccine

February 18, 2015
A 9-valent HPV vaccine safely and effectively prevented infection and disease related to five types of HPV not targeted by the quadrivalent vaccine, according to study…
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Henrik Falconer, MD, PhD In the Journals

Salpingectomy may reduce risk for ovarian cancer

February 27, 2015
Surgical removal of the fallopian tubes may help reduce a woman’s risk for ovarian cancer even if her ovaries are left intact, according to…
Richard T. Penson, MD In the Journals

Bevacizumab does not hinder quality of life for women with advanced cervical cancer

February 25, 2015
The addition of bevacizumab to treatment regimens for patients with advanced cervical cancer improved survival without sacrificing quality of life…
Jason D. Wright, MD In the Journals

Cancer prevalence low in women who undergo myomectomy with electric power morcellation

February 20, 2015
The prevalence of cancer and precancer abnormalities in the uterus was low among women who underwent myomectomy with electric power morcellation…
In the Journals

9-valent HPV vaccine noninferior to quadrivalent HPV vaccine

February 18, 2015
A 9-valent HPV vaccine safely and effectively prevented infection and disease related to five types of HPV not targeted by the quadrivalent vaccine…
Robert L. Coleman, MD In the Journals

Everolimus plus letrozole effective in recurrent endometrial carcinoma

February 17, 2015
The combination of everolimus and letrozole yielded high rates of objective response and clinical benefit in patients with recurrent endometrial…
In the Journals

Half of US teenage girls fail to receive HPV vaccine at recommended age

February 13, 2015
Despite increases, only 55.9% of adolescent girls received the HPV vaccine at the age currently recommended by the CDC’s Advisory Committee on…
In the Journals

Hormone replacement therapy increases risk for ovarian cancer

February 12, 2015
Women who used hormone replacement therapy — even only for a few years — demonstrated an increased risk for serous and endometrioid…
FDA NewsDrug Pipeline

FDA grants orphan drug designation to Reolysin for ovarian cancer

February 11, 2015
The FDA granted orphan drug designation to Reolysin for the treatment of ovarian cancer, according to a press release from the drug’s…
Maintaining public awareness is critical to solving the problem of drug shortages, according to J. Leonard Lichtenfeld, MD, MACP, deputy chief medical officer for the American Cancer Society. “If we don’t constantly revisit this and make people aware of it, then this will become the status quo,” he said. Cover StoryPublication Exclusive

Expectation of drug shortages has become ‘new norm’ for cancer care

HemOnc Today, February 10, 2015
More than 230 drugs appeared on the American Society of Health-System Pharmacists’ drug shortage list as of mid-January.The list — primarily…
Sven Mahner, MD In the Journals

Adjuvant radiotherapy may benefit patients with lymph node-positive vulvar cancer

February 3, 2015
Adjuvant radiotherapy may provide survival benefits for patients with lymph node-positive vulvar cancer, according to study results.Vulvar cancer is…
More Headlines »
morganatic-roan